647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review.

MLA

Sood, Siddhartha, et al. “647 - Upadacitinib Dose Alterations in Adolescent and Adult Patients with Atopic Dermatitis: A Real-World Multicenter Retrospective Review.” British Journal of Dermatology, vol. 191, Aug. 2024, pp. 1–2. EBSCOhost, https://doi.org/10.1093/bjd/ljae266.026.

APA

Sood, S., Rankin, B. D., Park, Y.-J., Rimke, A., Abduelmula, A., Georgakopoulos, J. R., Maliyar, K., Leung, F., Stark, L. A., Devani, A. R., Yeung, J., & Prajapati, V. H. (2024). 647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review. British Journal of Dermatology, 191, 1–2. https://doi.org/10.1093/bjd/ljae266.026

Chicago

Sood, Siddhartha, Brian D Rankin, Ye-Jean Park, Alexander Rimke, Abrahim Abduelmula, Jorge R Georgakopoulos, Khalad Maliyar, et al. 2024. “647 - Upadacitinib Dose Alterations in Adolescent and Adult Patients with Atopic Dermatitis: A Real-World Multicenter Retrospective Review.” British Journal of Dermatology 191 (August): 1–2. doi:10.1093/bjd/ljae266.026.